Neuromuscular Rehabilitation for ACL Injury Prevention in Athletes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on preventing a second ACL injury in young athletes who have already experienced one. It tests various rehab methods to determine which best helps athletes return to sports safely without reinjury. Participants will join one of three groups: a standard physical therapy group, a minimal home exercise group, or a neuromuscular training group (also known as Neuromuscular Intervention) that includes specific exercises to correct movement issues. Athletes who have had an ACL injury within the last six months, play sports involving quick movements, and have not undergone knee surgery are well-suited for this trial. As an unphased trial, it offers athletes the chance to explore innovative rehabilitation methods that could enhance recovery and prevent future injuries.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this neuromuscular intervention is safe for athletes?
Research has shown that neuromuscular training safely and effectively reduces the risk of ACL injuries. Studies indicate that this training can lower the chance of lower body injuries by about 27%. It includes exercises that strengthen the core and hips, helping to correct movement problems that might cause injuries.
In previous trials, athletes who participated in neuromuscular training experienced fewer ACL injuries. The training was well-received, and no major safety issues were reported. This makes it a promising option for preventing repeat ACL injuries in athletes.12345Why are researchers excited about this trial?
Researchers are excited about the neuromuscular rehabilitation technique because it focuses on correcting movement flaws that can lead to ACL injuries, which is a new approach compared to standard treatments that primarily emphasize strength, agility, and plyometric exercises. Unlike traditional methods, this innovative technique provides verbal and visual feedback during exercises to enhance core and hip strength, potentially reducing the risk of a second ACL injury. By incorporating neuromuscular training and single-leg drills, it targets specific weaknesses in movement patterns, offering a more personalized and dynamic rehabilitation strategy for athletes.
What evidence suggests that this trial's treatments could be effective for preventing a second ACL injury?
Studies have shown that neuromuscular training (NMT), which participants in the Intervention Group with Neuromuscular Training will receive, can effectively lower the risk of ACL injuries. For instance, NMT reduced the chance of an ACL injury from 1 in 54 to 1 in 111, nearly cutting the risk in half. Research also shows that NMT decreases the risk of lower body injuries by about 27%. This training includes exercises that strengthen the core and hips and correct movement problems, helping to prevent injuries during sports activities.36789
Who Is on the Research Team?
Aaron J Krych, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for active athletes aged between 14 and 24 who have had their first ACL injury within the last 6 months. They should not have had previous knee surgeries, complex meniscus tears, or other recent injuries that required medical care. Participants must have been involved in sports requiring cutting, jumping, or pivoting for at least 50 hours a year.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo different rehabilitation protocols including HOME, STAN, and TNMT over a six-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of knee kinematics and kinetics
What Are the Treatments Tested in This Trial?
Interventions
- Neuromuscular Intervention
Trial Overview
The study aims to reduce second ACL injuries by identifying high-risk individuals based on movement patterns and testing different rehab protocols after initial ACL reconstruction. The interventions being tested are HOME (home-based exercises) and TNMT (targeted neuromuscular training).
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Active Control
Patients who are enrolled in the TNMT group will participate in 12 sessions of supervised outpatient physical therapy over a six week period. The TNMT protocol is distinguished by performance of exercises designed to enhance core and hip strength, performance of neuromuscular training exercise that are designed to correct movement flaws associated with second ACL injury25, providing verbal and visual feedback and performance of single leg drills on both legs.
HOME Program is distinguished by patients participating in a home only intervention that consists of running and strengthening exercises performed twice a week for six weeks. No plyometric or agility drills are performed in this study arm. This represents the minimal intervention to prepare for a return to sports. No neuromuscular training or movement training beyond the sagittal plane will be performed.
Patients in the STAN group will participate in twelve sessions of supervised physical therapy over a six week period. Patients will participate in agility and plyometric drills, and continue strength exercises from the previous treatment phase. The clinic program will be performed in conjunction with a home running program. Patients in this group will not receive feedback from the therapist regarding movement quality during activities.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
Published Research Related to This Trial
Citations
A Systematic Review and Meta-analysis - PubMed - NIH
NMT reduced the risk for ACL injury from 1 in 54 to 1 in 111 (odds ratio [OR], 0.51; 95% CI, 0.37-0.69]). The overall mean training volume was 18.17 hours for ...
Effectiveness of Neuromuscular Training Based on the ...
The hypotheses were that (1) TNMT would decrease biomechanical and neuromuscular factors related to an increased ACL injury risk and (2) TNMT would decrease ...
The preventive effects of neuromuscular training on lower ...
Data from 24 included studies demonstrated that NMT reduced the overall risk of lower extremity injuries by 27 % (0.73, 95 % CI 0.67–0.79). Subgroup analyses by ...
Neuromuscular training to prevent ACL injuries in female ...
In comparison to the control group, neuromuscular training reduced ACL injury odds (OR 0.81, 95% CI 0.70–0.94). A significant improvement in ...
5.
scholars.indianastate.edu
scholars.indianastate.edu/cgi/viewcontent.cgi?article=1234&context=clinatEffective Anterior Cruciate Ligament Injury Prevention ...
Neuromuscular training (NMT) programs have been effective in reducing ACL injury risk in athletic populations, though additional clarity on ...
Team Approach: Neuromuscular Training for Primary and ...
Neuromuscular training has consistently been shown to reduce the risk of anterior cruciate ligament injury, particularly for athletes engaged in ...
7.
bmcmusculoskeletdisord.biomedcentral.com
bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/s12891-025-08647-3Outcomes of a randomized controlled trial of neuromuscular ...
The purpose of this study was to determine the effects of a randomized clinical trial to reduce a risk factor of ACL injuries, knee abduction moment (KAM),
Compliance With Neuromuscular Training and Anterior ...
Higher rates of compliance with neuromuscular training programs were associated with lower rates of anterior cruciate ligament (ACL) injury incidence among ...
Neuromuscular Rehabilitation in the Prevention of Anterior ...
This study aims to evaluate the effectiveness of neuromuscular training (NMT) programs in preventing ACL injuries in young populations.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.